The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses (Q41913682)

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Synergistic Antimalarial Activity of Pyrimethamine and Sulfadoxine against Plasmodium falciparum In Vitro *

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

In vitro activities of and mechanisms of resistance to antifol antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Measurement of the Potencies of Drug Mixtures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

A Method for Testing for Synergy with Any Number of Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Stage-specific sensitivity of Plasmodium falciparum to antifolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Falciparum malaria: differential effects of antimalarial drugs on ex vivo parasite viability during the critical early phase of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Treatment of malaria: some considerations and limitations of the current methods of assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Drug resistant malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Point mutations and pyrimethamine resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Pharmacology and parasitology: integrating experimental methods and approaches to falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Comparison of in vitro pyrimethamine assays and in vivo response to sulphadoxine-pyrimethamine in Plasmodium falciparum from Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Response of Plasmodium falciparum to dihydrofolate reductase inhibitors in Malindi, Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

The changing response of Plasmodium falciparum to antimalarial drugs in east Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Polymorphism of the alleles of the merozoite surface antigens MSA1 and MSA2 in Plasmodium falciparum wild isolates from Colombia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Mating patterns in malaria parasite populations of Papua New Guinea.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Clonal diversity in a single isolate of the malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Chloroquine treatment of falciparum malaria in an area of Kenya of intermediate chloroquine resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021

Falciparum malaria acquired in the area of the Thai-Khmer border resistant to treatment with Fansidar.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901124-1

7 January 2021